Wilson Sonsini advised Good Therapeutics on the deal. Good Therapeutics, a privately held company founded to create a new class of conditionally active therapeutics, announced it...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised Faeth Therapeutics on the deal. Faeth Therapeutics, a cancer metabolism company, announced the completion of a Series A financing of $47 million led...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised NAPIGEN on the deal. NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, announced the completion of $7.85 million seed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised VitroLabs on the deal. VitroLabs Inc, a Bay-Area-based biotech company leading the development of a new scientific process to grow the world’s first...
You must be a Standard 1 Year member to access this content.
